16:40 〜 16:45
○Atsumi NITTA1, Kohei HAMATANI1, Ryo INAGAKI1, Kequan FU1, Yuki OKETANI2, Kenji SATO2, Youta TORII2, Chikako HABUCHI2, Sekiguchi HIROTAKA2, Shuji IRITANI2, Norio OZAKI2, Shin-ichi MURAMATSU3, 4, Yoshiaki MIYAMOTO1 (1. Dept of Pharmaceutical Thera and Neuropharmacol, Fac of Pharmaceutical Sci. Grad Sch of Med and Pharm Sci.University of Toyama, Toyama, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 3. Division of Neurological Gene Therapy, Open Inovation Center, Jichi Medical University,Shimotsuke, Japan, 4. Center for Gene and Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)